risperdal quicklet 4 milligram orodispersible tablet
janssen-cilag ltd - risperidone - orodispersible tablet - 4 milligram - other antipsychotics
risperdal consta for injection 25 mgvial
johnson & johnson international (singapore) pte ltd - risperidone - injection, powder, for solution - 25 mg/vial - risperidone 25 mg/vial
risperdal consta for injection 37.5 mgvial
johnson & johnson international (singapore) pte ltd - risperidone - injection, powder, for solution - 37.5 mg/vial - risperidone 37.5 mg/vial
risperdal oral solution 1 mgml
johnson & johnson international (singapore) pte ltd - risperidone - solution - 1 mg/ml - risperidone 1 mg/ml
risperidex tablet 0.5mg
apex pharma marketing pte. ltd. - risperidone - tablet, film coated - 0.5mg - risperidone 0.5mg
risperidex tablet 1mg
apex pharma marketing pte. ltd. - risperidone - tablet, film coated - 1.0mg - risperidone 1.0mg
risperidex tablet 2mg
apex pharma marketing pte. ltd. - risperidone - tablet, film coated - 2.0mg - risperidone 2.0mg
risperidex tablet 4mg
apex pharma marketing pte. ltd. - risperidone - tablet, film coated - 4.0mg - risperidone 4.0mg
risperdal tablet 1 mg
johnson & johnson international (singapore) pte ltd - risperidone - tablet, film coated - 1 mg - risperidone 1 mg
risperidone 1mg/ml oral solution
rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.